 | • レポートコード：TPM-2JN055 • 出版社/出版日：Transparency Market Research / 2019年12月30日 • レポート形態：英文、PDF、207ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは梅毒イムノアッセイ診断の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場状況、市場動向、製品別分析、技術別分析、エンドユーザー別分析、地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、次の構成でお届けいたします。 ・序論 ・仮定・研究方法 ・エグゼクティブサマリー ・市場状況 ・市場動向 ・梅毒イムノアッセイ診断の世界市場：製品別 ・梅毒イムノアッセイ診断の世界市場：技術別 ・梅毒イムノアッセイ診断の世界市場：エンドユーザー別 ・梅毒イムノアッセイ診断の世界市場：地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ） ・梅毒イムノアッセイ診断の北米市場分析・予測 ・梅毒イムノアッセイ診断の欧州市場分析・予測 ・梅毒イムノアッセイ診断のアジア太平洋市場分析・予測 ・梅毒イムノアッセイ診断の中南米市場分析・予測 ・梅毒イムノアッセイ診断の中東・アフリカ市場分析・予測 ・競争状況 |
New innovations in syphilis analyzers are becoming increasingly mainstream in the syphilis immunoassay diagnostics market. As such, companies are launching new technologies in analyzers. For instance, in April 2019, Gold Standard Diagnostics – a provider of comprehensive diagnostic solutions, revealed the launch of its proprietary technology with a U.S. patent, which performs serological testing for syphilis.
Advancements in analyzer technologies are creating incremental opportunities for healthcare companies in the syphilis immunoassay diagnostics market space. There is increasing demand for advanced analyzers in hospitals and blood banks due to increase in the spending capacity of patients with STDs. Companies in the syphilis immunoassay diagnostics market are innovating in new technologies with the help of dedicated machines to automate rapid plasma regain (RPR) assays. They are improving testing capabilities for laboratories with the help of new software developments to enhance outcomes in patients.
Novel approaches of technological automation and machine learning are being adopted to develop first-of-its-kind diagnostics systems. The combination of approaches is helping clinical laboratories offer high-quality solutions for syphilis testing.
The growing trend of on-the-spot testing solutions has led to improvements in the syphilis immunoassay diagnostics landscape. For instance, clinical diagnostics company MBio, announced the launch of the LightDeck® platform, an innovative analytical technology that performs quantitative immunoassays and cell based assays. With the help of on-the-spot testing, companies in the syphilis immunoassay diagnostics market can tap into new business models, such as providing analytical testing services to the veterinary, food, military sectors.
Companies in the syphilis immunoassay diagnostics market are focused on expanding their product portfolios. They are increasing efforts to manufacture and sell instruments by acquiring licensing for the same. By these efforts, they are supporting the global OEM supply business model associated with various assays and their applications.
Healthcare industries are developing multiplexed immunoassay systems by experimenting on planar waveguide technology and fluorescence imaging. These efforts are being made to support outcomes in the ELISA (enzyme-linked immunosorbent assay) test, since ELISA currently accounts for the highest revenue in the syphilis immunoassay diagnostics market.
Recent advancements in molecular biology have led to the popularity of molecular diagnosis, such as the polymerase chain reaction (PCR), in the syphilis immunoassay diagnostics ecosystem. PCR technology is playing a crucial role in diagnosing syphilis. Healthcare industries in the syphilis immunoassay diagnostics market are developing various PCR methodologies that can be easily adapted in the clinical and laboratory environment. PCR is being increasingly associated with widespread application and deep exploration in the healthcare space.
Fast developments in PCR have led to advancements in real-time PCR, nested PCR, and multiplex PCR. The high sensitivity and specificity of PCR is well-suited for the diagnosis of early-stage syphilis. On the other hand, routine PCR is well-received in secondary syphilis. Healthcare companies in the syphilis immunoassay diagnostics market are increasing R&D to detect atypical cases of vertebral, ocular, and tonsillar syphilis with the help of molecular biology. Real-time PCR is gaining increased popularity for its ability to calculate the sum of pathogens that reveal the severity of the infection.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Syphilis Immunoassay Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Class Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Technological Advancement
5.2. Key Merger & Acquisition
5.3. Top Three Players- Analysis
5.4. Number of Syphilis Diagnostic Test, by Technology (2018)
5.5. Pricing Analysis by Technology
5.6. Disease Prevalence & Incidence Rate
6. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Product, 2017-2027
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2027
6.3.1. Analyzers
6.3.2. Kits & Reagents
6.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Product
7. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Technology, 2017-2027
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017–2027
7.3.1. ELISA
7.3.2. CLIA
7.3.3. Others
7.4. Market Attractiveness, by Technology
8. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Diagnostics Labs
8.3.3. Blood Banks
8.3.4. Others
8.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by End-user
9. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Region, 2017-2027
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Region
10. North America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
10.1. Introduction
10.1.1. Key Findings
10.2. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017–2027
10.2.1. Analyzers
10.2.2. Kits & Reagents
10.3. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
10.3.1. ELISA
10.3.2. CLIA
10.3.3. Others
10.4. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
10.4.1. Hospitals
10.4.2. Diagnostics Labs
10.4.3. Blood Banks
10.4.4. Others
10.5. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Country, 2017-2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Technology
10.6.3. By End-user
10.6.4. By Country
11. Europe Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
11.1. Introduction
11.1.1. Key Finding
11.2. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
11.2.1. Analyzers
11.2.2. Kits & Reagents
11.3. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
11.3.1. ELISA
11.3.2. CLIA
11.3.3. Others
11.4. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
11.4.1. Hospitals
11.4.2. Diagnostic Labs
11.4.3. Blood Banks
11.4.4. Others
11.5. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Russia
11.5.7. Turkey
11.5.8. Eastern Europe
11.5.9. Rest of Europe
11.6. Europe Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Technology
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
12.1. Introduction
12.1.1. Key Finding
12.2. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
12.2.1. Analyzers
12.2.2. Kits & Reagents
12.3. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
12.3.1. ELISA
12.3.2. CLIA
12.3.3. Others
12.4. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
12.4.1. Hospitals
12.4.2. Diagnostic Labs
12.4.3. Blood Banks
12.4.4. Others
12.5. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. South Korea
12.5.6. Vietnam
12.5.7. Rest of Asia Pacific
12.6. Asia Pacific Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Technology
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
13.1. Introduction
13.1.1. Key Finding
13.2. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
13.2.1. Analyzers
13.2.2. Kits & Reagents
13.3. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
13.3.1. ELISA
13.3.2. CLIA
13.3.3. Others
13.4. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
13.4.1. Hospitals
13.4.2. Diagnostic Labs
13.4.3. Blood Banks
13.4.4. Others
13.5. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast by Country/Sub-region, 2017-2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Technology
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
14.1. Introduction
14.1.1. Key Finding
14.2. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
14.2.1. Analyzers
14.2.2. Kits & Reagents
14.3. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
14.3.1. ELISA
14.3.2. CLIA
14.3.3. Others
14.4. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
14.4.1. Hospitals
14.4.2. Diagnostic Labs
14.4.3. Blood Banks
14.4.4. Others
14.5. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Maghreb
14.5.4. Rest of Middle East & Africa
14.6. Middle East & Africa Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Technology
14.6.3. By End-users
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis by Company (2018)
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Bio-Rad Laboratories, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. BD
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Siemens Healthineers AG
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. DiaSorin S.p.A.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Abbott
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Ortho Clinical Diagnostics (a part of Carlyle Group)
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Shenzhen New Industries Biomedical Engineering Co., Ltd.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. bioMérieux SA
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Fujirebio (Miraca Group) (Miraca Group)
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. Fujirebio (Miraca Group)
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Company Financials
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis
15.3.12. Danaher (Beckman Coulter, Inc.)
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Company Financials
15.3.12.3. Growth Strategies
15.3.12.4. SWOT Analysis
List of TablesTable 01: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 02: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 03: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 04: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017 - 2027
Table 05: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017 - 2027
Table 06: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 07: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 08: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 09: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 10: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 11: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 12: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 13: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 14: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 15: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 16: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 17: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 18: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 19: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 20: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 21: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 22: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
Table 23: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
Table 24: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast,